Correction: Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ

Correction: Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ

Bibliographic Details
Main Author:	The Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236189/?tool=EBI

Similar Items

Correction: Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ.
Published: (2014-01-01)

Neurologic abnormalities in mouse models of the lysosomal storage disorders mucolipidosis II and mucolipidosis III γ.
by: Rachel A Idol, et al.
Published: (2014-01-01)

Mucolipidosis III
by: Ibis Menéndez Alejo, et al.
Published: (1995-08-01)

Hip Morphology in Mucolipidosis Type II
by: Luise Sophie Ammer, et al.
Published: (2020-03-01)

Mucolipidosis II (I - Cell Disease)
by: Kumar T, et al.
Published: (2005-01-01)

ESCRT-Dependent Cell Death in a Caenorhabditis elegans Model of the Lysosomal Storage Disorder Mucolipidosis Type IV
by: Huynh, Julie
Published: (2015)

Mucolipidosis II: first report from Saudi Arabia
by: Majid Alfadhel, et al.
Published: (2013-07-01)

Mucolipidosis II: Estudio clínico, bioquímico y genético
by: Ibis Menéndez, et al.
Published: (1998-03-01)

C. elegans apoptosis : CED-4 translocation and involvement in a model of mucolipidosis type IV human lysosomal storage disorder
by: Hersh, Bradley Michael, 1973-
Published: (2005)

Comorbid Cardiovascular Malformation and Type II Mucolipidosis: Clinical Case
by: Nina V. Fedorova, et al.
Published: (2020-11-01)

CLINICAL AND GENETIC CHARACTERISTICS OF MUCOLIPIDOSIS II AND IIIA TYPES IN CHILDREN
by: A. N. Semyachkina, et al.
Published: (2017-06-01)

Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV
by: Molly Mepyans, et al.
Published: (2020-07-01)

Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV
by: Yulia Grishchuk, et al.
Published: (2015-12-01)

Development of an antisense-mediated exon skipping therapeutic strategy for Mucolipidosis II
by: Regina Filipa Machado Vilela
Published: (2019)

Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells
by: Jarrod W. Barnes, et al.
Published: (2020-04-01)

[PROVISIONAL] Humoral immune response in adult Brazilian patients with Mucolipidosis III gamma
by: Fernanda Sperb-Ludwig, et al.

Unique molecular signature in mucolipidosis type IV microglia
by: Antony Cougnoux, et al.
Published: (2019-12-01)

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
by: Nivethitha Arunkumar, et al.
Published: (2021-07-01)

Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
by: Mona L. Essawi, et al.
Published: (2021-08-01)

Is hematopoietic stem cell transplantation a therapeutic option for mucolipidosis type II?
by: Luise Sophie Ammer, et al.
Published: (2021-03-01)

Diagnóstico clínico y genético mucolipidosis II - enfermedad células de inclusión
by: Sandra Viviana Caceres Matta, et al.
Published: (2021-07-01)

Imbalanced cellular metabolism compromises cartilage homeostasis and joint function in a mouse model of mucolipidosis type III gamma
by: Lena Marie Westermann, et al.
Published: (2020-11-01)

Mutation Analysis of 16 Mucolipidosis II and III Alpha/Beta Chinese Children Revealed Genotype-Phenotype Correlations.
by: Shuang Liu, et al.
Published: (2016-01-01)

A GNPTAB nonsense variant is associated with feline mucolipidosis II (I-cell disease)
by: Ping Wang, et al.
Published: (2018-12-01)

Excessive activity of cathepsin K is associated with cartilage defects in a zebrafish model of mucolipidosis II
by: Aaron C. Petrey, et al.
Published: (2012-03-01)

Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
by: Furness, A., et al.
Published: (2022)

A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth
by: Ju Sun Heo, et al.
Published: (2012-11-01)

Placental pathology in an unsuspected case of mucolipidosis type II with secondary hyperparathyroidism in a premature infant
by: Parith Wongkittichote, et al.
Published: (2021-06-01)

Bilateral carpal tunnel syndrome and multiple trigger fingers in a child with mucolipidosis Type III disease
by: Ahmadreza Afshar
Published: (2011-01-01)

Systematic screens for proteins that interact with the mucolipidosis type IV protein TRPML1.
by: Ellen Spooner, et al.
Published: (2013-01-01)

Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV—A Review and Case Series
by: Aleksandra Jezela-Stanek, et al.
Published: (2020-06-01)

A de novo or germline mutation in a family with Mucolipidosis III gamma: Implications for molecular diagnosis and genetic counseling
by: Renata Voltolini Velho, et al.
Published: (2014-01-01)

GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report
by: Chi-Chun Ho, et al.
Published: (2018-09-01)

Transgenic inhibition of interleukin-6 trans-signaling does not prevent skeletal pathologies in mucolipidosis type II mice
by: Lena Marie Westermann, et al.
Published: (2021-02-01)

N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV
by: Lauren C. Boudewyn, et al.
Published: (2017-09-01)

Exome sequencing for mucolipidosis III: Detection of a novel GNPTAB gene mutation in a patient with a very mild phenotype
by: F. Sperb-Ludwig, et al.
Published: (2015-03-01)

Proteomics analysis of a human brain sample from a mucolipidosis type IV patient reveals pathophysiological pathways
by: Ayelet Vardi, et al.
Published: (2021-01-01)

Anaesthesia-Relevant Disease Manifestations and Perianaesthetic Complications in Patients with Mucolipidosis—A Retrospective Analysis of 44 Anaesthetic Cases in 12 Patients
by: Ammer, L.S, et al.
Published: (2022)

Gene therapy for the neurological manifestations in lysosomal storage disorders
by: Seng H. Cheng
Published: (2014-09-01)

CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder.
by: Pericles Calias, et al.
Published: (2012-01-01)

Cannot write session to /tmp/vufind_sessions/sess_ttedgrubi4vdqsfmc3atr486mp